NCT06030674 Measuring Environmental Tobacco and Cannabis: Pollutants and Exposures
| NCT ID | NCT06030674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-09-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an unblinded pilot study of an environmental exposure to secondhand cannabis smoke in one group of healthy nonsmokers.
Eligibility Criteria
Inclusion Criteria: \- Adult nonsmokers, aged 21-50, who: * Are healthy on the basis of medical history * Have systolic blood pressure \<150 * Have diastolic blood pressure \<100 * Have BMI between 18.1 and 34.9 * Able to perform moderate exercise, * Are not exposed to tobacco or cannabis SHS in their daily lives. (Nonsmoking status and low SHS exposure are determined by self-report on the screening questionnaire, salivary cotinine \< 10 ng/ml and THC \< 50 ng/m and exhaled CO2 below 4 ppm) Exclusion Criteria: * Current use of cannabis products, including CBD and edible THC products * Regular exposure to secondhand tobacco or cannabis smoke * Positive SARS-CoV-2 antibody test * Age 18 \< or \> 50 * Physician diagnosis of asthma, heart disease, hypertension, thyroid disease, diabetes, renal or liver impairment or glaucoma. * Unstable psychiatric condition (such as current major depression, history of schizophrenia or bipolar disorder) or current use of more than two psychiatric medications * Systolic blood pressure \> 150 * Diastolic blood pressure \> 100 * Pregnancy or breastfeeding (by urine hCG and/or history) * Alcohol or illicit drug dependence within the past 5 years * BMI \> 35 and \< 18 * Current illicit drug use (by history or urine test) * More than 1 pack year smoking history * Ever a daily marijuana smoker * Smoked anything within the last 2 months * Occupational exposure to smoke, dusts OR fumes * Concurrent participation in another clinical trial * Unable to communicate in English * No social security number
Contact & Investigator
Suzaynn F Schick
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06030674 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 50 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06030674 currently recruiting?
Yes, NCT06030674 is actively recruiting participants. Contact the research team at suzaynn.schick@ucsf.edu for enrollment information.
Where is the NCT06030674 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06030674 clinical trial?
NCT06030674 is sponsored by University of California, San Francisco. The principal investigator is Suzaynn F Schick at University of California, San Francisco. The trial plans to enroll 200 participants.